{"id":71246,"date":"2026-04-14T17:44:58","date_gmt":"2026-04-14T12:14:58","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=71246"},"modified":"2026-04-14T17:45:00","modified_gmt":"2026-04-14T12:15:00","slug":"hester-biosciences-q4-results-2026-preview","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/hester-biosciences-q4-results-2026-preview\/","title":{"rendered":"Hester Biosciences Q4 Results 2026: Date, Revenue, PAT And Analyst Outlook"},"content":{"rendered":"<p>Hester Biosciences (NSE: HESTERBIO) is set to announce its Q4 FY26 (January\u2013March 2026) results on May 12, 2026. Trading at Rs 1,680 as of April 2026 \u2014 down -36% from its 52-week high of Rs 2,650 \u2014 the stock enters this pivotal results event having already corrected meaningfully from peak levels. Q4 FY26 delivers the full-year FY26 performance and the first formal FY27 management guidance.<\/p><p>This preview covers the confirmed results date, analyst consensus estimates, five key performance factors, five risks to monitor, analyst ratings, and the complete share price outlook for Hester Biosciences ahead of Q4 FY26 results.<\/p><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Get free investment predictions from SEBI-registered analysts on Univest<\/strong><\/a>.<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/hester-biosciences-q4-results-2026-preview\/#Hester_Biosciences_Q4_Results_2026_Date\" title=\"Hester Biosciences Q4 Results 2026 Date\">Hester Biosciences Q4 Results 2026 Date<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/hester-biosciences-q4-results-2026-preview\/#Why_Q4_FY26_Matters\" title=\"Why Q4 FY26 Matters\">Why Q4 FY26 Matters<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/hester-biosciences-q4-results-2026-preview\/#Hester_Biosciences_Q4_FY26_Earnings_Estimates\" title=\"Hester Biosciences Q4 FY26 Earnings Estimates\">Hester Biosciences Q4 FY26 Earnings Estimates<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/hester-biosciences-q4-results-2026-preview\/#5_Key_Factors_Driving_Hester_Biosciences_Q4_FY26_Performance\" title=\"5 Key Factors Driving Hester Biosciences Q4 FY26 Performance\">5 Key Factors Driving Hester Biosciences Q4 FY26 Performance<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/hester-biosciences-q4-results-2026-preview\/#1_India_Branded_Generic_Growth\" title=\"1. India Branded Generic Growth\">1. India Branded Generic Growth<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/hester-biosciences-q4-results-2026-preview\/#2_US_Generic_Revenue\" title=\"2. US Generic Revenue\">2. US Generic Revenue<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/hester-biosciences-q4-results-2026-preview\/#3_CDMO_Revenue\" title=\"3. CDMO Revenue\">3. CDMO Revenue<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/hester-biosciences-q4-results-2026-preview\/#4_New_Product_Launches\" title=\"4. New Product Launches\">4. New Product Launches<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/hester-biosciences-q4-results-2026-preview\/#5_API_Cost_Normalisation\" title=\"5. API Cost Normalisation\">5. API Cost Normalisation<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/hester-biosciences-q4-results-2026-preview\/#5_Risks_to_Watch_in_Hester_Biosciences_Q4_FY26\" title=\"5 Risks to Watch in Hester Biosciences Q4 FY26\">5 Risks to Watch in Hester Biosciences Q4 FY26<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/hester-biosciences-q4-results-2026-preview\/#Risk_1_Input_Cost_Volatility\" title=\"Risk 1: Input Cost Volatility\">Risk 1: Input Cost Volatility<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/hester-biosciences-q4-results-2026-preview\/#Risk_2_Revenue_Concentration_Risk\" title=\"Risk 2: Revenue Concentration Risk\">Risk 2: Revenue Concentration Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/hester-biosciences-q4-results-2026-preview\/#Risk_3_Competitive_Pressure\" title=\"Risk 3: Competitive Pressure\">Risk 3: Competitive Pressure<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/hester-biosciences-q4-results-2026-preview\/#Risk_4_Regulatory_Environment\" title=\"Risk 4: Regulatory Environment\">Risk 4: Regulatory Environment<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/hester-biosciences-q4-results-2026-preview\/#Risk_5_Macroeconomic_Sensitivity\" title=\"Risk 5: Macroeconomic Sensitivity\">Risk 5: Macroeconomic Sensitivity<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/hester-biosciences-q4-results-2026-preview\/#Hester_Biosciences_Share_Price_and_Analyst_Ratings\" title=\"Hester Biosciences Share Price and Analyst Ratings\">Hester Biosciences Share Price and Analyst Ratings<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/hester-biosciences-q4-results-2026-preview\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/hester-biosciences-q4-results-2026-preview\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/hester-biosciences-q4-results-2026-preview\/#Q_When_is_Hester_Biosciences_Q4_results_2026_date\" title=\"Q: When is Hester Biosciences Q4 results 2026 date?\">Q: When is Hester Biosciences Q4 results 2026 date?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/hester-biosciences-q4-results-2026-preview\/#Q_What_is_Hester_Biosciences_Q4_FY26_revenue_estimate\" title=\"Q: What is Hester Biosciences Q4 FY26 revenue estimate?\">Q: What is Hester Biosciences Q4 FY26 revenue estimate?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/hester-biosciences-q4-results-2026-preview\/#Q_What_is_Hester_Biosciences_share_price_ahead_of_Q4_results\" title=\"Q: What is Hester Biosciences share price ahead of Q4 results?\">Q: What is Hester Biosciences share price ahead of Q4 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/hester-biosciences-q4-results-2026-preview\/#Q_Will_Hester_Biosciences_declare_a_dividend_in_Q4_2026\" title=\"Q: Will Hester Biosciences declare a dividend in Q4 2026?\">Q: Will Hester Biosciences declare a dividend in Q4 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/hester-biosciences-q4-results-2026-preview\/#Q_Which_analysts_have_a_Buy_rating_on_Hester_Biosciences\" title=\"Q: Which analysts have a Buy rating on Hester Biosciences?\">Q: Which analysts have a Buy rating on Hester Biosciences?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/hester-biosciences-q4-results-2026-preview\/#Q_What_were_Hester_Biosciences_Q3_FY26_results\" title=\"Q: What were Hester Biosciences Q3 FY26 results?\">Q: What were Hester Biosciences Q3 FY26 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/hester-biosciences-q4-results-2026-preview\/#Q_When_do_TCS_and_Infosys_announce_Q4_results_2026\" title=\"Q: When do TCS and Infosys announce Q4 results 2026?\">Q: When do TCS and Infosys announce Q4 results 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/hester-biosciences-q4-results-2026-preview\/#Q_Is_Hester_Biosciences_a_good_investment_ahead_of_Q4_results\" title=\"Q: Is Hester Biosciences a good investment ahead of Q4 results?\">Q: Is Hester Biosciences a good investment ahead of Q4 results?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/hester-biosciences-q4-results-2026-preview\/#Recent_Article\" title=\"Recent Article\">Recent Article<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Hester_Biosciences_Q4_Results_2026_Date\"><\/span><strong>Hester Biosciences Q4 Results 2026 Date<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>The Hester Biosciences Q4 FY26 results date is May 12, 2026. The board will approve Q4 and full-year FY26 financial results, consider a final dividend for FY26, and provide management&#8217;s first formal FY27 business outlook.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Company<\/strong><\/td><td><strong>Q4 Results Date<\/strong><\/td><td><strong>Key Metric to Watch<\/strong><\/td><\/tr><tr><td>TCS<\/td><td>April 9, 2026 (Declared)<\/td><td>FY27 CC guidance + deal TCV<\/td><\/tr><tr><td>Infosys<\/td><td>April 23, 2026<\/td><td>CC revenue growth range<\/td><\/tr><tr><td>HCL Technologies<\/td><td>April 22, 2026<\/td><td>CC growth + EBIT margin<\/td><\/tr><tr><td>HDFC Bank<\/td><td>April 19, 2026<\/td><td>NIM recovery + loan growth<\/td><\/tr><tr><td>Hester Biosciences<\/td><td>May 12, 2026<\/td><td>See estimates below<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Why_Q4_FY26_Matters\"><\/span><strong>Why Q4 FY26 Matters<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Q4 FY26 is the final quarter of FY2025\u201326 and carries the highest informational weight of any quarterly result. Beyond the Q4 standalone performance, the Hester Biosciences board on May 12, 2026 will deliver the complete FY26 annual performance, a final dividend recommendation, and the first formal FY27 guidance commentary \u2014 making this the single most important quarterly event for Hester Biosciences investors.<\/p><p>For Hester Biosciences in the Veterinary Vaccines \/ Pharma sector, Q4 captures the peak-season demand dynamics that typically deliver the quarter&#8217;s strongest operating leverage when execution conditions are favourable.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Hester_Biosciences_Q4_FY26_Earnings_Estimates\"><\/span><strong>Hester Biosciences Q4 FY26 Earnings Estimates<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"536\" src=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/14174209\/estimates-17-1024x536.jpg\" alt=\"Hester Biosciences Q4 FY26 analyst estimates \u2014 Revenue Rs 185 Cr, PAT Rs 22 Cr | univest.in\" class=\"wp-image-71252\" srcset=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/14174209\/estimates-17-1024x536.jpg 1024w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/14174209\/estimates-17-300x157.jpg 300w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/14174209\/estimates-17-768x402.jpg 768w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/14174209\/estimates-17-900x471.jpg 900w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/14174209\/estimates-17-600x314.jpg 600w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/14174209\/estimates-17-150x79.jpg 150w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/14174209\/estimates-17.jpg 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Access premium analyst research on Univest<\/strong><\/a>.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Metric<\/strong><\/td><td><strong>Q4 FY26 Estimate<\/strong><\/td><td><strong>Q3 FY26 Actual<\/strong><\/td><td><strong>Trend<\/strong><\/td><\/tr><tr><td>Revenue<\/td><td>Rs 185 Cr<\/td><td>Rs 165 Cr<\/td><td>Sequential improvement expected<\/td><\/tr><tr><td>Net Profit (PAT)<\/td><td>Rs 22 Cr<\/td><td>Rs 19 Cr<\/td><td>Normalisation in progress<\/td><\/tr><tr><td>Operating Margin<\/td><td>EBITDA 18%<\/td><td>Q3 FY26 level<\/td><td>Stable to improving<\/td><\/tr><tr><td>Volume \/ Revenue Growth<\/td><td>+12% volume YoY<\/td><td>Prior quarter<\/td><td>YoY improvement expected<\/td><\/tr><tr><td>Final Dividend (Expected)<\/td><td>Rs 5<\/td><td>FY26 interim dividends<\/td><td>Board decision on May 12, 2026<\/td><\/tr><\/tbody><\/table><\/figure><p>Screen <strong>Hester Biosciences<\/strong> live on the <a href=\"https:\/\/univest.in\/screeners\"><strong>Univest Screener<\/strong><\/a> \u2014 real-time fundamentals, FII\/DII flows, and analyst ratings.<\/p><p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> for live Q4 result alerts.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"5_Key_Factors_Driving_Hester_Biosciences_Q4_FY26_Performance\"><\/span><strong>5 Key Factors Driving Hester Biosciences Q4 FY26 Performance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"1_India_Branded_Generic_Growth\"><\/span><strong>1. India Branded Generic Growth<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>India pharmaceutical market growing at 8-10% annually. Q4 captures year-end prescription momentum.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"2_US_Generic_Revenue\"><\/span><strong>2. US Generic Revenue<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>ANDA approvals and generic launches drive US export revenue. First-to-file paragraphs provide 180-day exclusivity.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"3_CDMO_Revenue\"><\/span><strong>3. CDMO Revenue<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Contract manufacturing for global innovators provides long-term, high-margin revenue.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"4_New_Product_Launches\"><\/span><strong>4. New Product Launches<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>New OTC and branded generic launches in India expand domestic market share.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"5_API_Cost_Normalisation\"><\/span><strong>5. API Cost Normalisation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Global API price moderation benefits formulation company gross margins.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"5_Risks_to_Watch_in_Hester_Biosciences_Q4_FY26\"><\/span><strong>5 Risks to Watch in Hester Biosciences Q4 FY26<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Risk_1_Input_Cost_Volatility\"><\/span><strong>Risk 1: Input Cost Volatility<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Raw material and input cost changes can compress margins unexpectedly.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Risk_2_Revenue_Concentration_Risk\"><\/span><strong>Risk 2: Revenue Concentration Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Customer or geographic concentration creates quarterly variance.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Risk_3_Competitive_Pressure\"><\/span><strong>Risk 3: Competitive Pressure<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Intensified sector competition may require price or volume concessions.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Risk_4_Regulatory_Environment\"><\/span><strong>Risk 4: Regulatory Environment<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Policy and regulatory changes can create compliance cost or revenue risks.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Risk_5_Macroeconomic_Sensitivity\"><\/span><strong>Risk 5: Macroeconomic Sensitivity<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Global and domestic conditions \u2014 tariffs, interest rates, consumption \u2014 affect demand.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Hester_Biosciences_Share_Price_and_Analyst_Ratings\"><\/span><strong>Hester Biosciences Share Price and Analyst Ratings<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"536\" src=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/14174316\/share_analyst-10-1024x536.jpg\" alt=\"Hester Biosciences share price and analyst ratings \u2014 Q4 FY26 preview | univest.in\" class=\"wp-image-71254\" srcset=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/14174316\/share_analyst-10-1024x536.jpg 1024w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/14174316\/share_analyst-10-300x157.jpg 300w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/14174316\/share_analyst-10-768x402.jpg 768w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/14174316\/share_analyst-10-900x471.jpg 900w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/14174316\/share_analyst-10-600x314.jpg 600w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/14174316\/share_analyst-10-150x79.jpg 150w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/14174316\/share_analyst-10.jpg 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Parameter<\/strong><\/td><td><strong>Value<\/strong><\/td><\/tr><tr><td>CMP (April 2026)<\/td><td>Rs 1,680<\/td><\/tr><tr><td>52-Week High<\/td><td>Rs 2,650<\/td><\/tr><tr><td>52-Week Low<\/td><td>Rs 1,480<\/td><\/tr><tr><td>1-Year Return<\/td><td>-36%<\/td><\/tr><tr><td>Market Cap<\/td><td>Rs 1,200 Cr<\/td><\/tr><tr><td>Sector<\/td><td>Veterinary Vaccines \/ Pharma<\/td><\/tr><tr><td>NSE Ticker<\/td><td>HESTERBIO<\/td><\/tr><tr><td>Q4 Results Date<\/td><td>May 12, 2026<\/td><\/tr><\/tbody><\/table><\/figure><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Brokerage<\/strong><\/td><td><strong>Rating<\/strong><\/td><td><strong>Thesis Summary<\/strong><\/td><\/tr><tr><td>Motilal Oswal<\/td><td>BUY<\/td><td>Q4 recovery potential; sector tailwinds intact<\/td><\/tr><tr><td>YES Securities<\/td><td>ADD<\/td><td>Earnings inflection expected; FY27 guidance key<\/td><\/tr><tr><td>Kotak Institutional<\/td><td>NEUTRAL<\/td><td>Fair valued at current levels; execution key<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Hester Biosciences Q4 FY26 results on May 12, 2026 will be the most important quarterly event of FY26. At Rs 1,680 \u2014 down -36% from its 52-week high of Rs 2,650 \u2014 the stock has already priced in significant headwinds. Revenue above Rs 185 Cr with EBITDA 18% would constitute a beat versus analyst consensus. Management&#8217;s FY27 guidance is the primary re-rating catalyst that determines whether the current level represents an entry opportunity.<\/p><p><strong>Disclaimer: <\/strong>Investment in the share market is subject to risk. This article is for informational and educational purposes only and does not constitute investment advice. All data sourced from publicly available information. Verify before investing. Consult a SEBI-registered financial advisor before making investment decisions.<\/p><p>For more Q4 FY26 results previews, visit <a href=\"https:\/\/univest.in\/blogs\">Univest Blogs<\/a>.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_When_is_Hester_Biosciences_Q4_results_2026_date\"><\/span><strong>Q: When is Hester Biosciences Q4 results 2026 date?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Hester Biosciences Q4 FY26 results date is May 12, 2026. The board will approve the audited Q4 and full-year FY26 financial results, consider a final dividend, and provide FY27 guidance.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_What_is_Hester_Biosciences_Q4_FY26_revenue_estimate\"><\/span><strong>Q: What is Hester Biosciences Q4 FY26 revenue estimate?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Analyst consensus Q4 FY26 revenue estimate for Hester Biosciences is Rs 185 Cr. Q3 FY26 actual revenue was Rs 165 Cr. Actual results may differ based on operating conditions.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_What_is_Hester_Biosciences_share_price_ahead_of_Q4_results\"><\/span><strong>Q: What is Hester Biosciences share price ahead of Q4 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Hester Biosciences trades at Rs 1,680 as of April 2026. 52-week high is Rs 2,650; 52-week low is Rs 1,480. 1-year return is -36%. Market cap is Rs 1,200 Cr.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_Will_Hester_Biosciences_declare_a_dividend_in_Q4_2026\"><\/span><strong>Q: Will Hester Biosciences declare a dividend in Q4 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Hester Biosciences is expected to declare Rs 5 as final dividend for FY26, subject to board approval on May 12, 2026 and subsequent AGM shareholder approval.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_Which_analysts_have_a_Buy_rating_on_Hester_Biosciences\"><\/span><strong>Q: Which analysts have a Buy rating on Hester Biosciences?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Motilal Oswal has a BUY rating and YES Securities has an ADD rating on Hester Biosciences based on publicly available research. Check the Univest Screener for the latest analyst ratings.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_What_were_Hester_Biosciences_Q3_FY26_results\"><\/span><strong>Q: What were Hester Biosciences Q3 FY26 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Hester Biosciences reported Q3 FY26 revenue of Rs 165 Cr and PAT of Rs 19 Cr. The Q4 FY26 results on May 12, 2026 provide the full-year FY26 comparison and first FY27 guidance.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_When_do_TCS_and_Infosys_announce_Q4_results_2026\"><\/span><strong>Q: When do TCS and Infosys announce Q4 results 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>TCS declared Q4 FY26 results on April 9, 2026. HCL Technologies declared on April 22. HDFC Bank declared on April 19. Infosys Q4 FY26 results are scheduled for April 23, 2026.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_Is_Hester_Biosciences_a_good_investment_ahead_of_Q4_results\"><\/span><strong>Q: Is Hester Biosciences a good investment ahead of Q4 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>This article does not constitute investment advice. Hester Biosciences trades at Rs 1,680 \u2014 down -36% from its peak. Analyst consensus Q4 revenue estimate is Rs 185 Cr and PAT estimate is Rs 22 Cr. Review the five factors and five risks above. Consult a SEBI-registered financial advisor before investing.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Article\"><\/span><strong>Recent Article<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/balkrishna-industries-q4-results-2026\">Balkrishna Industries Q4 Results 2026: Date, Revenue, PAT &amp; Analyst Outlook<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/balkrishna-paper-mills-q4-results-2026\">Balkrishna Paper Mills Q4 Results 2026: Date, Revenue, PAT &amp; Analyst Outlook<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/balaxi-pharmaceuticals-q4-results-2026\">BALAXI PHARMACEUTICALS Q4 Results 2026: Date, Revenue, PAT &amp; Analyst Outlook<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/balaji-telefilms-q4-results-2026\">Balaji Telefilms Q4 Results 2026: Date, Revenue, PAT &amp; Analyst Outlook<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/balaji-amines-q4-results-2026\">Balaji Amines Q4 Results 2026: Date, Revenue, PAT &amp; Analyst Outlook<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Hester Biosciences (NSE: HESTERBIO) is set to announce its Q4 FY26 (January\u2013March 2026) results on May 12, 2026. Trading at Rs 1,680 as of April 2026 \u2014 down -36% from its 52-week high of Rs 2,650 \u2014 the stock enters this pivotal results event having already corrected meaningfully from peak levels. Q4 FY26 delivers the<\/p>\n","protected":false},"author":23,"featured_media":71250,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3983],"class_list":["post-71246","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-q4-results-2026"],"metadata":{"_edit_lock":["1776170798:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"amazonS3_cache":["a:10:{s:62:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/04\/image-771.jpeg\";a:2:{s:2:\"id\";i:71248;s:11:\"source_type\";s:13:\"media-library\";}s:94:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/14174010\/image-771.jpeg\";a:2:{s:2:\"id\";i:71248;s:11:\"source_type\";s:13:\"media-library\";}s:64:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/04\/estimates-17.jpg\";a:2:{s:2:\"id\";i:71252;s:11:\"source_type\";s:13:\"media-library\";}s:73:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/04\/estimates-17-1024x536.jpg\";a:2:{s:2:\"id\";i:71252;s:11:\"source_type\";s:13:\"media-library\";}s:96:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/14174209\/estimates-17.jpg\";a:2:{s:2:\"id\";i:71252;s:11:\"source_type\";s:13:\"media-library\";}s:105:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/14174209\/estimates-17-1024x536.jpg\";a:2:{s:2:\"id\";i:71252;s:11:\"source_type\";s:13:\"media-library\";}s:68:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/04\/share_analyst-10.jpg\";a:2:{s:2:\"id\";i:71254;s:11:\"source_type\";s:13:\"media-library\";}s:77:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/04\/share_analyst-10-1024x536.jpg\";a:2:{s:2:\"id\";i:71254;s:11:\"source_type\";s:13:\"media-library\";}s:100:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/14174316\/share_analyst-10.jpg\";a:2:{s:2:\"id\";i:71254;s:11:\"source_type\";s:13:\"media-library\";}s:109:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/14174316\/share_analyst-10-1024x536.jpg\";a:2:{s:2:\"id\";i:71254;s:11:\"source_type\";s:13:\"media-library\";}}"],"rank_math_primary_category":["842"],"rank_math_seo_score":["78"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"rank_math_title":["Hester Biosciences Q4 Results 2026: Date, Revenue, PAT And Analyst Outlook"],"rank_math_description":["Hester Biosciences Q4 results date is May 12, 2026. Revenue estimate Rs 185 Cr, PAT estimate Rs 22 Cr. 5 factors, 5 risks, analyst ratings and share price outlook for 2026."],"rank_math_focus_keyword":["Hester Biosciences Q4 Results"],"_thumbnail_id":["71250"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["8092"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/14174040\/Hester-Biosciences-Q4.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/71246","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=71246"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/71246\/revisions"}],"predecessor-version":[{"id":71256,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/71246\/revisions\/71256"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/71250"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=71246"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=71246"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=71246"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}